Ledger.Open graph →
SEC Form D · Amendment · filed November 8, 2013

Kalyra Pharmaceuticals, Inc

Offering
$7.0M
Sold
$6.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Scott L. Glenn · San Diego, CADirectorKevin D. Bunker · Escondido, CAExec · DirectorNed A. Israelsen · Escondido, CADirectorDirk A. Thye · Escondido, CADirectorCam L. Garner · San Diego, CADirectorScott L. Glenn · Del Mar, CADirectorCam Gallagher · San Diego, CAExecMichael E. Breede · San Deigo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗